|
|
||||||||


* Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109;
Center for Immunology, Mount Sinai School of Medicine, New York, NY 10029; and
Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710
We have established a defect in CCR6/ mice in response to a cockroach allergen airway challenge characterized by decreased IL-5 production, reduced CD4+ T and B cells as well as decreased eosinophil accumulation. To determine the nature of the defect in CCR6/ mice T lymphocyte populations from allergen-sensitized wild-type mice were transferred into sensitized CCR6/ mice. The reconstituted response was characterized by an increase in IL-5 levels, eosinophil accumulation, and serum IgE levels in recipient CCR6/ mice. Analysis of lymphocytes from draining lymph nodes of CCR6+/+ and CCR6/ sensitized or challenged mice demonstrated a significant decrease in IL-5 and IL-13 production in CCR6/ mice. In contrast, the systemic response in allergen-rechallenged spleen cells demonstrated no significant alteration in allergen-induced cytokine production. Transfer of isolated splenic T lymphocytes from sensitized CCR6+/+ mice induced airway hyperresponsiveness in wild-type but not CCR6/ naive mice, suggesting that T cells alone were not sufficient to induce airway hyperresponsiveness in CCR6/ mice. Additional analysis demonstrated decreased CD11c+, CD11b+ and CD11c, and B220 subsets of dendritic cells in the lungs of CCR6/ mice after allergen challenge. Using in vitro cell mixing studies with isolated pulmonary CD4+ T cells and CD11c+ cells from CCR6+/+ or CCR6/ mice, we demonstrate alterations in both CCR6/ T cells and CCR6/ pulmonary APCs to elicit IL-5 responses. Altogether, the defect in CCR6/ mice appears to be primarily due to an alteration in T cell activation, but also appears to include local pulmonary APC defects.
This article has been cited by other articles:
![]() |
M. A. Schaller, R. Neupane, B. D. Rudd, S. L. Kunkel, L. E. Kallal, P. Lincoln, J. B. Lowe, Y. Man, and N. W. Lukacs Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines J. Exp. Med., November 26, 2007; 204(12): 2925 - 2934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Facco, I. Baesso, M. Miorin, M. Bortoli, A. Cabrelle, E. Boscaro, C. Gurrieri, L. Trentin, R. Zambello, F. Calabrese, et al. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis J. Leukoc. Biol., October 1, 2007; 82(4): 946 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Regamey, C. Obregon, S. Ferrari-Lacraz, C. van Leer, M. Chanson, L. P. Nicod, and T. Geiser Airway Epithelial IL-15 Transforms Monocytes into Dendritic Cells Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 75 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Phadke, G. Akangire, S. J. Park, S. A. Lira, and B. Mehrad The Role of CC Chemokine Receptor 6 in Host Defense in a Model of Invasive Pulmonary Aspergillosis Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1165 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Robays, T. Maes, S. Lebecque, S. A. Lira, W. A. Kuziel, G. G. Brusselle, G. F. Joos, and K. V. Vermaelen Chemokine Receptor CCR2 but Not CCR5 or CCR6 Mediates the Increase in Pulmonary Dendritic Cells during Allergic Airway Inflammation J. Immunol., April 15, 2007; 178(8): 5305 - 5311. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. MEDOFF, S. Y. THOMAS, A. BANERJI, J. C. WAIN, H. ZHANG, C. M. LILLY, L. C. GINNS, and A. D. LUSTER Pathogenic T-Cell Recruitment into the Airway in Human Disease Ann. N.Y. Acad. Sci., December 1, 2005; 1062(1): 220 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vermaelen and R. Pauwels Pulmonary Dendritic Cells Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 530 - 551. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |